Brain Science: Psychiatry at Amyloid Beta’s Era of Alzheimer’s Research
For decades, Amyloid beta, Aβ, was the dominant target of Alzheimer’s disease [AD] research. It got all the attention, funding, efforts and trials, across universities, journals, pharma, biotech, ...